INJECTAFER is now the first and only intravenous iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
. | June 5, 2023
/PRNewswire/ CSL Vifor today announced that the U.S. Food and Drug Administration (FDA) has granted its partner American Regent, Inc., a Daiichi Sankyo.
American Regent® Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
American Regent® Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.